Executive at Apria Healthcare LLC
- Benefit of Philips’ (AMS: PHIA) CPAP (continuous positive airway pressure) device recall for ResMed (NYSE: RMD) demand volume for sleep and respiratory care devices, including sustainability and size of increased demand
- ResMed’s near-term supply chain issues, including issues keeping up with increased demand leading to customers moving to other providers such as 3B
- Philips’ future position in the CPAP market following device recall
- ResMed’s recent launch of AirSense 11, including uptake and product differentiation
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.